Progress of Ginsenoside Rb1 in neurological disorders
Ginseng is frequently used in traditional Chinese medicine to treat neurological disorders. The primary active component of ginseng is ginsenoside, which has been classified into more than 110 types based on their chemical structures. Ginsenoside Rb1 (GsRb1)-a protopanaxadiol saponin and a typical g...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Book |
| Published: |
Frontiers Media S.A.,
2024-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_7e2ee14a8a8e419da19c4957b976b80d | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Gongxia Ling |e author |
| 700 | 1 | 0 | |a Min Zhang |e author |
| 700 | 1 | 0 | |a Chizhang Chen |e author |
| 700 | 1 | 0 | |a Yan Wang |e author |
| 700 | 1 | 0 | |a Qiqi Gao |e author |
| 700 | 1 | 0 | |a Jianshun Li |e author |
| 700 | 1 | 0 | |a Hao Yuan |e author |
| 700 | 1 | 0 | |a Wenwen Jin |e author |
| 700 | 1 | 0 | |a Wei Lin |e author |
| 700 | 1 | 0 | |a Lingrong Yang |e author |
| 245 | 0 | 0 | |a Progress of Ginsenoside Rb1 in neurological disorders |
| 260 | |b Frontiers Media S.A., |c 2024-01-01T00:00:00Z. | ||
| 500 | |a 1663-9812 | ||
| 500 | |a 10.3389/fphar.2024.1280792 | ||
| 520 | |a Ginseng is frequently used in traditional Chinese medicine to treat neurological disorders. The primary active component of ginseng is ginsenoside, which has been classified into more than 110 types based on their chemical structures. Ginsenoside Rb1 (GsRb1)-a protopanaxadiol saponin and a typical ginseng component-exhibits anti-inflammatory, anti-oxidant, anti-apoptotic, and anti-autophagy properties in the nervous system. Neurological disorders remain a leading cause of death and disability globally. GsRb1 effectively treats neurological disorders. To contribute novel insights to the understanding and treatment of neurological disorders, we present a comprehensive review of the pharmacokinetics, actions, mechanisms, and research development of GsRb1 in neurological disorders. | ||
| 546 | |a EN | ||
| 690 | |a Ginsenoside Rb1 | ||
| 690 | |a pharmacokinetics | ||
| 690 | |a actions | ||
| 690 | |a mechanisms | ||
| 690 | |a neurological disorders | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Frontiers in Pharmacology, Vol 15 (2024) | |
| 787 | 0 | |n https://www.frontiersin.org/articles/10.3389/fphar.2024.1280792/full | |
| 787 | 0 | |n https://doaj.org/toc/1663-9812 | |
| 856 | 4 | 1 | |u https://doaj.org/article/7e2ee14a8a8e419da19c4957b976b80d |z Connect to this object online. |